Updated analysis and exploratory analysis of primary tumor location in the TRICOLORE trial: A randomized phase III trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer

M. Nakamura, A. Takashima, T. Denda, M. Gamoh, I. Iwanaga, Y. Komatsu, M. Takahashi, H. Ohori, T. Sekikawa, M. Tsuda, Y. Kobayashi, Y. Miyamoto, M. Kotake, C. Ishioka, K. Shimada, A. Sato, S. Yuki, S. Morita, S. Takahashi, T. Yamaguchi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)viii159
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
Publication statusPublished - 2018 Oct 1

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this